Exotoxin A Purification via Alkaline Low-Urea Solubilization

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for purifying proteins, such as Exotoxin A, from inclusion bodies require high concentrations of chaotropic agents, leading to protein denaturation and a cumbersome refolding process, which is inefficient and labor-intensive.

Innovation Solution

A method involving solubilization in a mildly denaturing urea solution at alkaline pH, followed by dilution and purification using immobilized metal ion affinity chromatography (IMAC) and chitin columns, allows for the recovery of active Exotoxin A proteins from both soluble and insoluble fractions without complete unfolding.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Quantity of substance

If high concentrations of chaotropic agents are used to solubilize inclusion bodies, then protein solubilization is achieved, but protein denaturation occurs and refolding process becomes cumbersome

Engineering Contradiction:
Improveprotein solubilization efficiencyVSAvoidrefolding process complexity
Core Design Contradiction:
Quantity of substanceVSDevice complexity

Solution Approach 1:

The patent changes the pH parameter to alkaline conditions (pH 12.0) and uses low concentration urea (2M) instead of high concentration chaotropic agents. This parameter change allows solubilization of inclusion bodies without complete protein denaturation, eliminating the need for cumbersome refolding processes while maintaining protein solubility

Inventive Principle:
Principle #35Parameter changes

2Reliability

If traditional purification methods are used from soluble fraction, then protein activity is maintained, but purification efficiency and productivity are low

Engineering Contradiction:
Improveprotein activity retentionVSAvoidpurification efficiency
Core Design Contradiction:
ReliabilityVSProductivity

Solution Approach 1:

The patent performs preliminary solubilization of inclusion bodies under alkaline conditions with low concentration urea before purification. This preliminary action prevents complete denaturation and maintains protein activity, while the subsequent dilution step (1:10 with neutral pH buffer) prepares the sample for efficient chromatographic purification, thereby improving overall productivity

Inventive Principle:
Principle #10Preliminary action

3Manufacturing precision

If inclusion bodies are used as protein source, then protein purity and resistance to proteolytic degradation are improved, but solubilization requires harsh conditions

Engineering Contradiction:
Improveprotein purityVSAvoidharsh solubilization conditions
Core Design Contradiction:
Manufacturing precisionVSObject-affected harmful factors

Solution Approach 1:

The patent changes the solubilization conditions by using alkaline pH (12.0) combined with low concentration urea (2M) instead of harsh conditions like 6-8M urea or strong detergents. This milder approach maintains the purity benefits of using inclusion bodies while reducing the harshness of solubilization conditions, preventing complete protein denaturation

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This method simplifies and accelerates the purification process, maintaining protein activity and achieving high purity, with reproducible results across batches, superior to traditional protocols.

Implementation Method 1

solubilizing the sample in a solubilization buffer containing urea and at alkaline pH, wherein the solubilization buffer contains urea at a concentration in the range of from 1.8 to 2.2M and has a buffer pH in the range of from 11.5 to 12.5

Methodology Applied
Scientific EffectUrea denaturation:

Implementation Method 2

purification is performed by chromatographic separation by passing the diluted protein through one immobilized metal ion affinity chromatography (IMAC) column or one IMAC and one chitin column

Methodology Applied
Scientific EffectAffinity chromatography: Adsorption

Implementation Method 3

purification is performed by chromatographic separation by passing the diluted protein through one immobilized metal ion affinity chromatography (IMAC) column or one IMAC and one chitin column

Methodology Applied
Scientific EffectChitin affinity binding: Adsorption

Data Source

PatentEP3370777B1Purification method for recombinant exotoxin a, recombinant exotoxin a muteins and recombinant proteins comprising exotoxin a fragments
Publication Date: 2020.07.29 UNIWERSYTET WARSZAWSKI
  • EP3370777B1 patent drawingFigure 1~2
  • EP3370777B1 patent drawingFigure 3a~4b
  • EP3370777B1 patent drawingFigure 5~6

AI summary

A method for purifying a protein comprising an Exotoxin A, Exotoxin A mutein or fragment thereof, the method comprising:(a) solubilizing a sample comprising the protein in a solubilization buffer containing a low concentration of urea and at an alkaline pH,and (b) decreasing the concentration of urea and the pH by dilution using a dilution buffer, and / or by dialysis into a dilution buffer,prior to purification of the protein.